Determination of the Characteristics of Isometric Gastric Motility Measurement in Healthy Volunteers

NCT ID: NCT03441230

Last Updated: 2018-02-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

8 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-02-15

Study Completion Date

2017-01-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

There is a clear need for a novel method that can readily assess gastric motility in daily clinical practice. Isometric determination of the stomach motility would avoid the use of a large flaccid balloon while still being affordable. The aim of this study was to determine the optimal balloon characteristics that enable to measure motility-induced pressure changes in healthy volunteers.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gastroparesis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Circumference of 13 cm, sphere form (diameter of 4 cm)

Group Type ACTIVE_COMPARATOR

Balloon characteristics

Intervention Type DEVICE

Different size balloon

Circumference of 13 cm, cylinder form, length 11 cm

Group Type ACTIVE_COMPARATOR

Balloon characteristics

Intervention Type DEVICE

Different size balloon

Circumference of 16 cm, sphere form (diameter of 5 cm)

Group Type ACTIVE_COMPARATOR

Balloon characteristics

Intervention Type DEVICE

Different size balloon

Circumference of 16 cm, cylinder form, length 11 cm

Group Type ACTIVE_COMPARATOR

Balloon characteristics

Intervention Type DEVICE

Different size balloon

Circumference of 16 cm, cylinder form, length 18 cm

Group Type ACTIVE_COMPARATOR

Balloon characteristics

Intervention Type DEVICE

Different size balloon

Circumference of 19 cm, sphere form (diameter of 6 cm)

Group Type ACTIVE_COMPARATOR

Balloon characteristics

Intervention Type DEVICE

Different size balloon

Circumference of 19 cm, cylinder form, length 11 cm

Group Type ACTIVE_COMPARATOR

Balloon characteristics

Intervention Type DEVICE

Different size balloon

Circumference of 22 cm, sphere form (diameter of 7 cm)

Group Type ACTIVE_COMPARATOR

Balloon characteristics

Intervention Type DEVICE

Different size balloon

Circumference of 25 cm, sphere form (diameter of 8 cm)

Group Type ACTIVE_COMPARATOR

Balloon characteristics

Intervention Type DEVICE

Different size balloon

Circumference of 28 cm, sphere form (diameter of 9 cm)

Group Type ACTIVE_COMPARATOR

Balloon characteristics

Intervention Type DEVICE

Different size balloon

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Balloon characteristics

Different size balloon

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* They are between 18-60 years old.
* Male and female.
* Patients must provide witnessed written informed consent prior to any study procedures being performed.

Exclusion Criteria

* They are older than 60 years old and younger than 18 years.
* They are taking medication.
* Have severely decreased kidney function.
* Have severely decreased liver function.
* Have severe heart disease, for example a history of irregular heartbeats, angina or heart attack.
* Have severe lung disease.
* Have severe psychiatric illness or neurological illness.
* Have any gastrointestinal disease.
* Have any dyspeptic symptoms.
* Women that are pregnant or breastfeeding.
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Prof Dr Jan Tack

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Prof Dr Jan Tack

Prof. Dr.

Responsibility Role SPONSOR_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Hospitals Leuven

Leuven, Vlaams-Brabant, Belgium

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Belgium

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

S58817

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Evaluation of Vital Capacity
NCT02022072 TERMINATED PHASE2